STM publisher Springer has signed a co-development partnership with the American Society of Gene & Cell Therapy (ASGCT) for the publication of books to be included in the Springer series Advances in Experimental Medicine and Biology. The agreement is to publish four edited volumes per year in the field of gene and cell therapy.
ASGCT will hold editorial responsibility for the books and Springer will handle production, marketing, sales and distribution. The books will be available as eBooks on Springer's online platform, springerlink.com, and in print-to-order (PTO) format.
ASGCT seeks to advance knowledge, awareness and education leading to the discovery and clinical application of genetic and cellular therapies. The society is a catalyst for bringing together scientists, physicians, patient advocates and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
Search for more Biology related STM journals
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
